Philippines - English - FDA (Food And Drug Administration)

patient care corportation; distributor: patient care corportation - iohexol - solution for (iv) injection - 647mg/ml (equivalent to 300mg iodine)

Philippines - English - FDA (Food And Drug Administration)

patient care corportation; distributor: patient care corportation - iohexol - solution for injecion (i.v) - 755 mg/ml (equivalent to the 350mg of iodine)

Philippines - English - FDA (Food And Drug Administration)

patient care corportation; distributor: patient care corportation - iopamidol - solution for (iv) injection - 612mg/ml (equivalent to 300mg iodine)

Australia - English - Department of Health (Therapeutic Goods Administration)

i-care pharma distributors pty ltd - ocriplasmin, quantity: 1.25 mg/ml - injection, solution - excipient ingredients: mannitol; citric acid monohydrate; sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - jetrea rtu is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

Australia - English - Department of Health (Therapeutic Goods Administration)

total patient care pty ltd - 40896 - patient positioning device, diagnostic imaging/radiotherapy, moulding, thermoplastic - a thermoplastic material used to create moulds of a patient's body. it is commonly supplied as sheets or meshes of thermoplastic material that have been coated with polyurethane for ease of handling and positioning. most of these materials are softened by heating in hot water and while softened, are moulded around the patient's anatomy. when cooled, it hardens to form a custom-made mould or cast of that part of the body. after the moulding process is complete, it is typically attached to a board, frame, or other patient positioning or immobilization device.

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 1000mg - film coated tablet - 1000 mg - active: levetiracetam 1000mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry white 85f18422 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 250mg - film coated tablet - 250 mg - active: levetiracetam 250mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry blue 85f20694 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 500mg - film coated tablet - 500 mg - active: levetiracetam 500mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry yellow 85f32004 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

New Zealand - English - Medsafe (Medicines Safety Authority)

psm healthcare ltd trading as api consumer brands - levetiracetam 750mg - film coated tablet - 750 mg - active: levetiracetam 750mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate maize starch opadry orange 85f23452 povidone purified talc - use in epileptic patients aged 6 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (jme). add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 6 years of age with idiopathic generalized epilepsy (ige).

Australia - English - Department of Health (Therapeutic Goods Administration)

novis healthcare pty ltd - 40535 - lift, patient transfer, sling/harness/strap - this is a single use all round sling designed to work with a patient lift or hoist that will fit the majority of users and hoisting situations in both institutional and homecare environments. the is ideal for hoisting users to and from lying positions and from the floor. they are ergonomically designed for making hoisting comfortable for both the user and the carer, whilst aiming to retain the safety of the user during transfers.